News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
75,149 Results
Type
Article (1986)
Company Profile (4)
Press Release (73159)
Section
Business (25654)
Career Advice (10)
Deals (4616)
Drug Development (8247)
FDA (1825)
Job Trends (831)
News (37483)
Policy (3653)
Tag
2027 BioCapital Standard (1)
2027 Biotech Beach Standard (1)
Academia (107)
Accelerated approval (5)
ADA (2)
Allergies (27)
Alliances (8212)
ALS (23)
Alzheimer's disease (196)
Antibody-drug conjugate (ADC) (145)
Approvals (2015)
Artificial intelligence (41)
ASCO (39)
Autoimmune disease (44)
Automation (4)
Bankruptcy (10)
Best Places to Work (612)
BIO (9)
Biologics (7)
Biosimilars (106)
BioSpace Insights (1)
Biotechnology (6)
Bispecific (9)
Bladder cancer (33)
Brain cancer (9)
Breast cancer (73)
Cancer (739)
Cardiovascular disease (29)
Career advice (10)
CAR-T (19)
CDC (2)
CDMO (12)
Celiac Disease (1)
Cell therapy (77)
Cervical cancer (5)
Clinical research (7943)
Collaboration (365)
Commercialization (12)
Compensation (28)
Complete response letters (9)
COVID-19 (212)
CRISPR (1)
C-suite (121)
Cystic fibrosis (9)
Data (996)
Depression (18)
Dermatology (20)
Diabetes (55)
Diagnostics (668)
Digital health (8)
Drug discovery (46)
Drug pricing (1)
Duchenne muscular dystrophy (52)
Earnings (8383)
ESMO (54)
Events (7906)
Executive appointments (83)
Eye disease (1)
FDA (2408)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (1)
Funding (176)
Gene editing (7)
Generative AI (1)
Gene therapy (45)
GLP-1 (93)
Government (280)
Grass and pollen (1)
Guidances (41)
Healthcare (1167)
Hematology (14)
HIV (7)
Huntington's disease (3)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (30)
Immunology and inflammation (7)
Immuno-oncology (15)
Indications (34)
Infectious disease (242)
Inflammatory bowel disease (26)
Inflation Reduction Act (1)
Influenza (15)
Intellectual property (44)
IPO (1661)
Job creations (244)
Job search strategy (10)
JPM (3)
Kidney cancer (2)
Kidney disease (13)
Layoffs (6)
Legal (968)
Licensing (26)
Liver cancer (22)
Longevity (3)
Lung cancer (139)
Lung diease (3)
Lymphoma (62)
Machine learning (1)
Manufacturing (165)
Marketing (10)
MASH (20)
Medical device (1202)
Medtech (1223)
Mergers & acquisitions (3177)
Metabolic disorders (131)
mRNA (10)
Multiple sclerosis (28)
NASH (1)
Neurodegenerative disease (44)
Neuropsychiatric disorders (7)
Neuroscience (400)
NextGen: Class of 2026 (237)
Non-profit (71)
Now hiring (1)
Obesity (45)
Opinion (3)
Ovarian cancer (44)
Pain (24)
Pancreatic cancer (35)
Parkinson's disease (66)
Partnered (4)
Patents (81)
Patient recruitment (96)
Patient selection (18)
Peanut (2)
People (5363)
Peptides (1)
Pharmaceutical (2)
Pharmacy benefit managers (5)
Phase 1 (2153)
Phase 2 (3387)
Phase 3 (3006)
Pipeline (1600)
Policy (1)
Postmarket research (242)
Preclinical (719)
Press Release (2)
Prostate cancer (30)
Radiopharmaceuticals (29)
Rare diseases (103)
Real estate (618)
Regenerative medicine (5)
Regulatory (3201)
Reports (9)
Research institute (101)
Rett syndrome (1)
RNA editing (3)
RSV (3)
Schizophrenia (27)
Series A (38)
Series B (25)
Service/supplier (1)
Sickle cell disease (9)
Spinal muscular atrophy (5)
Sponsored (1)
Startups (429)
Stem cells (1)
Stomach cancer (3)
Substance use disorders (2)
Supply chain (15)
Switzerland (5)
Vaccines (53)
Venture capital (7)
Weight loss (20)
Women's health (10)
Date
Today (13)
Last 7 days (89)
Last 30 days (269)
Last 365 days (2947)
2026 (2463)
2025 (2720)
2024 (3312)
2023 (3865)
2022 (7086)
2021 (6505)
2020 (5951)
2019 (3961)
2018 (3072)
2017 (3582)
2016 (3193)
2015 (4048)
2014 (3035)
2013 (2616)
2012 (2823)
2011 (2931)
2010 (2688)
Location
Africa (98)
Alabama (5)
Arizona (16)
Arkansas (1)
Asia (22479)
Australia (2516)
California (981)
Canada (530)
China (594)
Colorado (6)
Connecticut (30)
Delaware (9)
Europe (13716)
Florida (100)
Georgia (18)
Hawaii (1)
Illinois (50)
India (69)
Indiana (36)
Japan (389)
Kansas (5)
Louisiana (3)
Maine (4)
Maryland (139)
Massachusetts (729)
Michigan (9)
Minnesota (41)
Missouri (3)
Nebraska (3)
Nevada (16)
New Hampshire (1)
New Jersey (581)
New York (312)
North Carolina (138)
Northern California (424)
Ohio (8)
Oregon (1)
Pennsylvania (174)
Puerto Rico (1)
Rhode Island (1)
South America (110)
South Carolina (1)
Southern California (488)
Tennessee (6)
Texas (70)
United States (3591)
Utah (38)
Vermont (1)
Virginia (72)
Washington D.C. (3)
Washington State (68)
Wisconsin (9)
Wyoming (1)
75,149 Results for "aspen pharmacare ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Aspen Pharmacare Canada receives Health Canada approval for a generic equivalent of Ozempic®
July 22, 2026
·
3 min read
Press Releases
Aspen Neuroscience Announces Pricing of Initial Public Offering - October 29, 2026
October 30, 2026
·
4 min read
Press Releases
Aspen Neuroscience Announces Publication of Sasineprocel Preclinical Data in “Cell Stem Cell”
September 20, 2026
·
3 min read
Press Releases
Aspen Medical Products Strengthens Executive Leadership Team with Appointment of Steve Paul as President
August 27, 2026
·
3 min read
Press Releases
Cytokinetics Launches ASPEN-HCM: A Real-World Study Evaluating MYQORZO® (aficamten) in Symptomatic Obstructive Hypertrophic Cardiomyopathy
September 30, 2026
·
12 min read
Funding
Aspen’s $115M Series C Opens Doors to Late-Stage Development for Parkinson’s Program
Aspen is now also considering the possibility of an initial public offering next year in an effort to bring its cell therapy to the market.
November 20, 2025
·
1 min read
·
Tristan Manalac
Press Releases
Aspen Neuroscience Appoints Jeff Boerneke as General Counsel and Secretary
June 11, 2026
·
3 min read
Press Releases
ClearPoint Neuro Congratulates Partner Aspen Neuroscience on FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Sasineprocel
August 2, 2026
·
7 min read
Press Releases
Aspen Neuroscience Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Sasineprocel (ANPD001) to Treat Parkinson’s Disease
July 30, 2026
·
4 min read
Press Releases
ALX Oncology Announces Nature Medicine Publication of ASPEN-06 Phase 2 Clinical Data Demonstrating Strong Responses and Durable Clinical Benefit with Evorpacept in HER2-Positive Gastric Cancer
September 28, 2026
·
6 min read
1 of 7,515
Next
